Inhibition of herpes simplex virus infection by oligomeric stilbenoids through ROS generation

被引:51
作者
Chen, Xiaoqing [1 ,2 ,3 ]
Qiao, Haishi [1 ,2 ,3 ]
Liu, Taixiang [1 ,2 ,3 ]
Yang, Ziying [1 ]
Xu, Lanfang [1 ]
Xu, Yunxia [1 ]
Ge, Hui Ming [1 ]
Tan, Ren-Xiang [1 ]
Li, Erguang [1 ,2 ,3 ]
机构
[1] Nanjing Univ, Sch Med, State Key Lab Pharmaceut Biotechnol, Coll Life Sci, Nanjing 210093, Peoples R China
[2] Nanjing Univ, Sch Med, Nanjing 210093, Jiangsu, Peoples R China
[3] Jiangsu Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China
关键词
Herpes simplex virus; Resveratrol; Stilbenoid; Reactive oxygen species; KAPPA-B; RESVERATROL; P53; ANTIOXIDANT; ACTIVATION; TYPE-1; OLIGOSTILBENOIDS; PEROXIDATION; RECOGNITION; MECHANISMS;
D O I
10.1016/j.antiviral.2012.05.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stilbenoids including resveratrol contain the basic structural unit of 1,2-diphenylethylene. Naturally occurring stilbenoids have broad structural features due to oligomerization and modifications and some have demonstrated potent biological activities. In an effort to identify bioactive stilbenoids, we screened a group of dimeric and oligomeric stilbenoids against HSV-1 and HSV-2 infection. Several trimeric and tetrameric derivatives showed anti-herpetic activity at single digit micromolar concentrations. HSV-1 and HSV-2 replication requires for NF-kappa B and MAPK activation. The compounds showed no inhibitory activity against NF-kappa B and Erk/MAPK activation, instead those compounds promoted rapid and transient release of reactive oxygen species (ROS). Addition of N-acetylcysteine (NAC), a scavenger of ROS, reversed the inhibitory effect of those compounds against HSV replication. In addition to the identification of resveratrol derivatives with potent anti-HSV activity, our results uncover a mechanism of polyphenol-mediated anti-HSV response, linking anti-herpetic activity of oligomeric stilbenoids to innate immunity. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 52 条
[1]   Activation of IκB kinase by herpes simplex virus type 1 -: A novel target for anti-herpetic therapy [J].
Amici, C ;
Belardo, G ;
Rossi, A ;
Santoro, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :28759-28766
[2]   Resveratrol: A review of preclinical studies for human cancer prevention [J].
Athar, Mohammad ;
Back, Jung Ho ;
Tang, Xmwel ;
Kim, Kwang Ho ;
Kopelovich, Levy ;
Bickers, David R. ;
Kim, Arianna L. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) :274-283
[3]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[4]   Treating HIV infection with drugs for HSV-2 infection? [J].
Buve, Anne ;
Lynen, Lutgarde .
LANCET, 2010, 375 (9717) :782-784
[5]   Antiviral activity of resveratrol [J].
Campagna, Michela ;
Rivas, Carmen .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 :50-53
[6]   Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation [J].
Chen, Xiaoqing ;
Wang, Zhongxia ;
Yang, Ziying ;
Wang, Jingjing ;
Xu, Yunxia ;
Tan, Ren-xiang ;
Li, Erguang .
ANTIVIRAL RESEARCH, 2011, 92 (02) :341-345
[7]   Synergistic copathogens - HIV-1 and HSV-2 [J].
Corey, Lawrence .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :854-856
[8]   Effect of resveratrol on herpes simplex virus vaginal infection in the mouse [J].
Docherty, JJ ;
Fu, MM ;
Hah, JM ;
Sweet, TJ ;
Faith, SA ;
Booth, T .
ANTIVIRAL RESEARCH, 2005, 67 (03) :155-162
[9]   Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice [J].
Docherty, JJ ;
Smith, JS ;
Fu, MM ;
Stoner, T ;
Booth, T .
ANTIVIRAL RESEARCH, 2004, 61 (01) :19-26
[10]   CHARACTERIZATION OF HERPES SIMPLEX VIRUS STRAINS DIFFERING IN THEIR EFFECTS ON SOCIAL BEHAVIOUR OF INFECTED CELLS [J].
EJERCITO, PM ;
KIEFF, ED ;
ROIZMAN, B .
JOURNAL OF GENERAL VIROLOGY, 1968, 2 :357-&